COVID-19 vaccine value — $1.9T BioNTech / $5.2T total

SARS-CoV-2 genome shared publicly January 10-11, 2020 via virological.org and GISAID. BioNTech Project Lightspeed launched January 27, 2020 (17 days later); 8 vaccine candidates designed within 48 hours of the founders' decision. Pfizer joined March 17, 2020. Pfizer-BioNTech generated ~$1.9T global economic value, part of $5.2T across all COVID-19 vaccines.

Use: E-0062, C-0032.

Original whitepaper reference: [113]